The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Hamill John P.

Reporting owner CIK 0001716213 · SrVP/CFO/Prin Fin & Acct Ofcr

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Hamill John P.Hamill John P.Hamill John P. · December 10, 2025 · Purchase · Common WarrantHamill John P. · December 10, 2025 · Purchase · Common StockDec 10, 2025Dec 10, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

2 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 10, 2025Aprea Therapeutics, Inc.Common WarrantHamill John P.Purchase
Dec 10, 2025Aprea Therapeutics, Inc.Common StockHamill John P.Purchase

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Aprea Therapeutics, Inc.APRE · company listings
Hamill John P.SrVP/CFO/Prin Fin & Acct Ofcr
PurchaseCommon WarrantDerivative security · Code P5,000Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Aprea Therapeutics, Inc.APRE · company listings
Hamill John P.SrVP/CFO/Prin Fin & Acct Ofcr
PurchaseCommon StockNon-derivative security · Code P5,0001.165Value: 5,825Currency not specifiedView ↗